CRD.B vs. EHTH, MMC, AON, AJG, BRO, SLQT, WDH, GOCO, RDZN, and FANH
Should you be buying Crawford & Company stock or one of its competitors? The main competitors of Crawford & Company include eHealth (EHTH), Marsh & McLennan Companies (MMC), AON (AON), Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), SelectQuote (SLQT), Waterdrop (WDH), GoHealth (GOCO), Roadzen (RDZN), and Fanhua (FANH). These companies are all part of the "insurance agents, brokers, & service" industry.
Crawford & Company (NYSE:CRD.B) and eHealth (NASDAQ:EHTH) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, community ranking, institutional ownership, media sentiment and risk.
In the previous week, eHealth had 2 more articles in the media than Crawford & Company. MarketBeat recorded 3 mentions for eHealth and 1 mentions for Crawford & Company. eHealth's average media sentiment score of 0.96 beat Crawford & Company's score of 0.00 indicating that eHealth is being referred to more favorably in the news media.
Crawford & Company has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, eHealth has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500.
Crawford & Company has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.
Crawford & Company has a net margin of 1.76% compared to eHealth's net margin of -5.36%. Crawford & Company's return on equity of 26.52% beat eHealth's return on equity.
eHealth has a consensus price target of $10.00, suggesting a potential upside of 68.92%. Given eHealth's higher possible upside, analysts clearly believe eHealth is more favorable than Crawford & Company.
eHealth received 314 more outperform votes than Crawford & Company when rated by MarketBeat users. Likewise, 62.19% of users gave eHealth an outperform vote while only 54.02% of users gave Crawford & Company an outperform vote.
11.0% of Crawford & Company shares are owned by institutional investors. Comparatively, 79.5% of eHealth shares are owned by institutional investors. 51.0% of Crawford & Company shares are owned by company insiders. Comparatively, 4.1% of eHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Crawford & Company beats eHealth on 9 of the 16 factors compared between the two stocks.
Get Crawford & Company News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRD.B and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRD.B and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
CRD.B vs. The Competition
Crawford & Company Competitors List
Related Companies and Tools